Skip to main content

Agilent Technologies, Inc.

A
Exchange
NYSE
Industry
Laboratory Analytical Instruments
SEC CIK
0001090872

In the last 90 days, Agilent Technologies, Inc. insiders filed 0 open-market purchases and 1 sale; 1,135 institutions reported holding it in 13F filings for Q2 2026, worth $34.6B in total; Greenhaven Associates is the only superinvestor holding it.

Holders of 5% or more of A

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Agilent Technologies, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of A
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A8.30%23.6M shares–Apr 17, 20251 filingApr 17, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

2 Schedule 13D and 13G filings on Agilent Technologies, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on A
Filed (ET)FilerFormStakeChangeEvent dateFiling
Apr 17, 20259:35 AM ETBlackRock, Inc.13G/A8.30%23.6M shares–Mar 31, 2025SEC
Feb 13, 202510:09 AM ETMassachusetts Financial Services Co13G/A4.40%12.4M shares–Below 5%Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Agilent Technologies, Inc. shares.

No Form 144 notices for Agilent Technologies, Inc. are on file.